| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |